Donna Serure, DO
Dermatology · Smithtown, NYNPI 1356494231
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.8% of the total across 301 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 36 manufacturers, the largest accounting for just 18.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,931 and has fallen 76.8% since, to $449 in 2025.
Across 301 payments — averaging $26.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$1K
- Merz North America, Inc.$1K
- AbbVie$738
- LEO Pharma Inc.$601
- VYNE Pharmaceuticals Inc.$403
- Janssen Scientific Affairs, LLC$382
- plus $3K from 30 others
What the payments were for
- Food & beverage$7,33994%
- Education$4876%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 48 | $1,448 |
| Merz North America, Inc. | 5 | $1,096 |
| AbbVie | 32 | $738 |
| LEO Pharma Inc. | 27 | $601 |
| VYNE Pharmaceuticals Inc. | 28 | $403 |
| Janssen Scientific Affairs, LLC | 3 | $382 |
| Novartis | 20 | $377 |
| Sanofi | 13 | $367 |
| Biofrontera Inc. | 14 | $321 |
| Genentech USA, Inc. | 19 | $249 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 9 | $167 |
| Amgen | 6 | $160 |
| Almirall LLC | 9 | $152 |
| Sun Pharmaceutical Industries Inc. | 8 | $144 |
| Regeneron Healthcare Solutions, Inc. | 4 | $112 |
| Pfizer | 6 | $104 |
| Galderma Laboratories, L.p. | 6 | $96 |
| Revance Therapeutics, Inc. | 2 | $92 |
| Dermira, Inc. | 4 | $90 |
| EPI Health, LLC | 4 | $85 |
| Lilly USA, LLC | 4 | $84 |
| Incyte Corporation | 3 | $81 |
| Bristol Myers Squibb | 3 | $73 |
| Strata Skin Sciences, Inc. | 5 | $61 |
| Mayne Pharma Commercial LLC | 3 | $58 |
| UCB, Inc. | 3 | $55 |
| Sandoz | 2 | $37 |
| Boehringer Ingelheim | 1 | $36 |
| Arcutis Biotherapeutics, Inc. | 2 | $31 |
| Mission Pharmacal Company | 2 | $26 |
| Verrica Pharmaceuticals Inc. | 1 | $21 |
| Botanix SB Inc | 1 | $19 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $17 |
| Journey Medical Corporation | 1 | $16 |
| Smith+Nephew | 1 | $16 |
| Encore Dermatology Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,826 in reported general payments places this provider in the 70th percentile of 1,151 dermatology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 29 | $736 |
| Metronidazole | 16 | $689 |
| Triamcinolone Acetonide | 15 | $232 |
| Ammonium Lactate | 11 | $172 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Smithtown
- Michael FastenbergSmithtown$357K
- Alexandra GolantNew York$3.6M
- David CohenNew York$3M
- Michael CameronNew York$2.6M
- Saakshi KhattriNew York$2.4M
- Amy WechslerNew York$2.4M
- Jeffrey WeinbergKew Gardens$2.3M
- Joshua ZeichnerNew York$2.1M
- Russell CohenOceanside$2.1M
- Jeffrey LaducaAuburn$1.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.